| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 519,913 | 264,126 | 26,466 | 119,274 | | Cost of Revenue | 45,617 | 24,906 | 3,852 | 428,085 | | | Gross Profit | 474,296 | 239,220 | 22,614 | (308,811) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 209,829 | 155,566 | 74,644 | (330,035) | | Non Recurring | (30) |
-
| 30 | 86,023 | | Others | 66,413 | 42,977 | 4,214 | 14,580 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 220,964 | 40,677 | (56,274) | (79,379) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 18,288 | 177 | 28 | 201 | | Earnings Before Interest And Taxes | 216,372 | 40,854 | (56,246) | (79,178) | | Interest Expense | 31,183 | 30,909 | 28,902 | 30,649 | | Income Before Tax | 185,189 | 9,945 | (85,148) | (109,827) | | Income Tax Expense | 77,575 | 2,557 | (31,867) | (53,078) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 107,614 | 7,388 | (53,281) | (56,749) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 107,614 | 7,388 | (53,281) | (56,749) | | Preferred Stock And Other Adjustments | (1) | (1) | 1 |
-
| | | Net Income Applicable To Common Shares | $107,613 | $7,387 | ($53,280) | ($56,749) |
|
0.51% Nasdaq 
Income Statement
